RankingsPricing
  1. US-listed companies
  2. APPLIED DNA SCIENCES INC

APPLIED DNA SCIENCES INCAPDN

Market cap
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Sep 30,
2011		Sep 30,
2019		Sep 30,
2020		Sep 30,
2021		Sep 30,
2022
Product revenues-2615,43032
Service revenues-31937,735759,138
Clinical laboratory service revenues---516
Total revenues-52918
Product revenues---12
Clinical laboratory service revenues---311
Cost of Revenue-877,613720,900-13
Gross profit----5
Selling, general and administrative810101315
Research and development268,8763344
Impairment losses---821,741-
Total operating expenses914141819
LOSS FROM OPERATIONS-8,056,457-9,124,271-12,534,999-13,113,821-13,969,763
Interest income, net--162,432-115,83013,6757,200
Gain (Loss) on Extinguishment of Debt--1,260,399--1,774,662-
Unrealized gain on change in fair value of warrants classified as a liability-----17,999,521
Gain on extinguishment of notes payable---839,945-
Transaction costs related to warrant liabilities-----1,668,112
Loss on issuance of warrants----11
Other expense, net--43,299-378,075-243,576-47,305
Loss before provision for income taxes-10,515,124-8,617,446-13,028,904-14,278,439-8,270,059
Provision for income taxes-15,000---
NET LOSS--8,632,446-13,028,904-14,278,439-8,270,059
Less: Net (income) loss attributable to noncontrolling interest--9,323-1,6858,003-2,168
NET LOSS attributable to Applied DNA Sciences, Inc.-10,515,124-8,623,123-13,027,219-14,278,439-8,267,891
Deemed dividend related to warrant modifications--309,6072,842-110,105
NET LOSS attributable to common stockholders--8,932,730-13,030,061-14,286,442-8,377,996
Earnings Per Share, Basic----2.07-0.93
Earnings Per Share, Diluted----2.07-0.93